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Abstract
The Ca2+-binding protein (CaBP) parvalbumin (PV) is strongly
expressed in cerebellar Purkinje neurones (PNs). It is con-
sidered a pure Ca2+ buffer, lacking any Ca2+ sensor function.
Consistent with this notion, no PV ligand was found in dend-
rites of PNs. Recently, however, we observed for a related
CaBP that ligand-targeting differs substantially between
dendrites and axons. Thus, here we quantiﬁed the diffusion of
dye-labelled PV in axons, somata and nuclei of PNs by two-
photon ﬂuorescence recovery after photobleaching (FRAP). In
all three compartments the ﬂuorescence rapidly returned to
baseline, indicating that no large or immobile PV ligand was
present. In the axon, FRAP was well described by a one-
dimensional diffusion equation and a diffusion coefﬁcient (D)
of 12 (IQR 6–20) lm2/s. For the soma and nucleus a three-
dimensional model yielded similar D values. The diffusional
mobility in these compartments was 3 times smaller than in
dendrites. Based on control experiments with ﬂuorescein
dextrans, we attributed this reduced mobility of PV to different
cytoplasmic properties rather than to speciﬁc PV interactions
in these compartments. Our ﬁndings support the notion that
PV functions as a pure Ca2+ buffer and will aid simulations of
neuronal Ca2+ signalling.
Keywords: calcium, diffusion, diffusion equation, ﬂuores-
cence recovery after photobleaching.
The intracellular free Ca2+ concentration ([Ca2+]i) is a key
regulator of fundamental cellular processes. Ca2+ acts as a
second messenger via specialized Ca2+-binding proteins
(CaBPs) that show Ca2+-dependent regulation of downstream
effectors. Distinct from such Ca2+ sensors are pure buffers,
which bind Ca2+ but lack a Ca2+-dependent interaction with
other proteins (Celio et al. 1996). In the following we will
use ‘CaBP’ as the generic term for both sensors and buffers.
Owing to its potent action, the spatiotemporal extent of
[Ca2+]i is strictly controlled by endogenous CaBPs and
clearance mechanisms. In this process, mobile CaBPs
compete with immobile binding sites and pumps for Ca2+
binding. They increase the range of Ca2+ signals even if they
diffuse at a slower rate than free Ca2+ ions (for review see
Augustine et al. 2003). Besides their binding kinetics, the
mobility of the individual CaBPs and their action as buffer or
sensor are therefore major determinants of cellular Ca2+
signalling.
The CaBP parvalbumin (PV) is expressed in large
concentrations in distinct subpopulations of neurones, inclu-
ding speciﬁc interneurones in many brain regions and
cerebellar Purkinje neurones (PNs) (Celio 1990; Baimbridge
et al. 1992). It belongs to the family of EF-hand CaBPs and
was the ﬁrst member of this family to be discovered
(reviewed in Celio et al. 1996). The most prominent member
of the EF-hand family is calmodulin, which appears to be the
primary Ca2+ sensor in eukaryotic cells. On the contrary, PV
is typically considered to function as a pure Ca2+ buffer,
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although to our knowledge the absence of downstream PV
targets has only been shown in frog skeletal muscle cells
(Maughan and Godt 1999) and in spines and dendrites of
rodent PNs (Schmidt et al. 2003a). Although it is tempting to
generalize the functional classiﬁcation of PV as a pure buffer
based on these observations, we recently found that the
related CaBP calbindin-D28k binds to myo-inositol-mono-
phosphatase in spiny dendrites of PNs but not in axons
(Schmidt et al. 2005). Thus, although PV lacks an interaction
partner in dendrites (Schmidt et al. 2003a), this observation
cannot readily be transferred to other structures, not even
within the same cell.
Under physiological conditions, the Ca2+-binding kinetic
of PV is slow because it has to be preceded by unbinding of
Mg2+ for which PV also shows signiﬁcant afﬁnity. Further-
more, its Ca2+ dissociation rate is rather slow (Lee et al.
2000). As a result of this particular binding characteristic, PV
accelerates the initial decay rate of Ca2+ transients and
introduces a second component to the decay that summates
during repetitive stimulation (Lee et al. 2000; Schmidt et al.
2003b; Collin et al. 2005). Although the functional relevance
of this peculiar PV action is still obscure in dendritic Ca2+
signalling, for presynaptic sites it has been shown that it
modulates short-term plasticity and delayed transmitter
release (Caillard et al. 2000; Collin et al. 2005). Further-
more, PV expression in PNs appears to be 10-fold stronger
in the axon (‡ 1 mM) than in the perikarion and dendrites
(50–100 lM) (Kosaka et al. 1993), which might hint towards
a predominantly axonal function. In the light of these
ﬁndings, it was of particular interest to determine the axonal
diffusion of PV and to clarify whether or not a binding
partner for PV is present in the axon.
One means of quantifying the cytosolic mobility of
CaBPs and to concomitantly identify target proteins, i.e. a
possible sensor function, is by ﬂuorescence recovery after
photobleaching (FRAP; for a review see Reits and Neefjes
2001; Sprague et al. 2004). In the present study, we used
two-photon FRAP to investigate the mobility of dye-
labelled PV (PV*) in the axon and to search for possible
axonal binding partners. In addition, we analysed the
mobility of PV* in the soma and nucleus of PNs. Our
results indicate that PV* freely diffuses in all three
compartments and that none of them contains a large
(‡ 9 kDa) or immobile interaction partner, indicating that
PV is indeed a mere Ca2+ buffer and has no additional
sensor function in rodent PNs.
Experimental procedures
Slice preparation and solutions
Acute cerebellar brain slices were prepared from 21–24-day-old
mice that were decapitated under isoﬂurane (Curamed, Karlsruhe,
Germany) anaesthesia. The vermis was removed and mounted in
a chamber ﬁlled with cooled (0–2C) artiﬁcial cerebrospinal
ﬂuid (ACSF) below). Parasagittal slices 200 lm thick were cut
using a vibratome (HR2, Sigmann Elektronik, Hu¨ffenhardt,
Germany) and kept in ACSF at 35C for 45 min before they
were transferred to the recording chamber. Experiments were
performed at 20–22C.
The ACSF contained 125 mM NaCl, 2.5 mM KCl, 1.25 mM
NaH2PO4, 26 mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2 and 20 mM
glucose (pH 7.3–7.4 at 20–22C when gassed with 95% O2 and 5%
CO2). The pipette solution was composed of 140 mM potassium
gluconate, 10 mM NaCl, 3 mM Mg-ATP, 0.3 mM Na-GTP, 10 mM
HEPES, 0.1 mM dye-labelled PVor 0.5 mM ﬂuorescein dextran (FD;
10 or 40 kDa) dissolved in puriﬁed water (Sigma, St Louis, MO,
USA). The pH was adjusted to 7.3 with KOH. All chemicals were
from Sigma. Puriﬁed rat recombinant PV expressed in Escherichia
coli was labelled with Alexa-488 (Molecular Probes, Eugene, OR,
USA) as described previously (Schmidt et al. 2003a). Labelling
conditions (pH 9.0) were selected to preferentially label the a-amino
group of PV, while e-amino groups were not labelled signiﬁcantly.
The labelled protein was puriﬁed on a size exclusion column
(20 · 0.8 cm, gel volume 10 mL) containing Bio-Gel P-6 (medium,
fractionation range 1–6 kDa; Bio-Rad, Hercules, CA, USA) to
remove the unbound dye. In general, 0.3–1 mL labelling reaction
mixture was applied to the column and eluted with buffer [50 mM
(NH4)HCO3, 0.1 mM CaCl2, pH 8.3]. The molecular Alexa/PV ratio
was  0.8.
Dye loading and electrical recordings
PNs were equilibrated with the dye-containing pipette solution for
30 min in the whole-cell patch-clamp conﬁguration. Up to ) 300 pA
holding current was injected to keep the membrane potential at ) 60
to ) 65 mV using an Axopatch 200A ampliﬁer (Axon Instruments
Inc., Union City, CA, USA), a LIH 1600 AD/DA converter and
Patch Master 1.0 software (HEKA, Lamprecht, Germany). The latter
components were also used to control a Pockels cell (model 350–50
KD*P; Conoptics, Danbury, CT, USA). Patch pipettes were pulled
from borosilicate glass (Hilgenberg) with a PP-830 puller (Nari-
shige) to resistances of 4–6 MW. To allow rapid loading of the cells,
the series resistance was kept below 25 MW for at least 15 min after
breaking into the cell.
FRAP recordings and data analysis
As described in detail previously (Schmidt et al. 2003a), two-photon
FRAP experiments were performed between 30 and 120 min after the
whole-cell conﬁguration had been established using a custom-
modiﬁed Fluoview 300 laser-scanning microscope (Olympus,
Hamburg, Germany) equipped with a mode-locked Ti : sapphire
laser (Tsunami; Spectra Physics, Darmstadt, Germany) set to a centre
wavelength of 765 nm. The laser intensity was modulated with a
Pockels cell and focused on to the specimen by a 60 ·/0.9 NAwater
immersion objective (Olympus). The ﬂuorescence was detected
(photomultiplier tube) and sampled with the Fluoview system in the
point mode (sampling frequency 250 kHz, 2 or 0.1–0.2 ms binning
for cellular or aqueous FRAP recordings respectively). The laser
intensity was set to a monitoring value of 4–10 mW (measured at the
exit of the objective). After a 0.3-s baseline recording, a bleach pulse
(1–6 ms, 35–65 mW) was applied and the recovery of the ﬂuores-
cence monitored for 1.5 s. After recording the ﬂuorescence signal, the
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specimen background, laser intensity and system background were
recorded by defocusing, by deﬂecting scattered laser light towards the
photomultiplier tube, and by completely blocking the laser beam,
respectively, using the same intensity protocol.
Data analysis was performed with custom written routines in
Igor Pro 5.02 (Wavemetrics, Lake Oswego, OR, USA). The
ﬂuorescence data were corrected for the specimen background, and
the laser intensity data for the system background. The ﬂuores-
cence was subsequently divided by the square of the laser intensity
(Brown et al. 1999), and normalized to the baseline ﬂuorescence.
Data were only accepted for analysis if the initial bleaching during
the baseline period was less than 15%. The ﬁrst second of the
recovery of the axonal ﬂuorescence (F) was ﬁtted with a one-
dimensional diffusion equation of the form
F ðtÞ ¼ Fi þ F1
X1
n¼0
ðbÞn
n!
1
1þ nþ 16Dtnx2r
 1=2 ½1
where D is the diffusion coefﬁcient, F¥ is the postbleach
ﬂuorescence after recovery, Fi is an offset from the prebleach
amplitude (F0 ¼ 1) which would indicate immobilization of
PV*, b is the bleach depth parameter (Brown et al. 1999) and
xr is the radial e
)2 radius of the two-photon excitation volume.
Equation 1 was derived by ﬁrst determining the time evolution of
the concentration distribution in one dimension, which itself
can be derived from the full three-dimensional (3D) case
[equation V in Brown et al. (1999)] by taking the limit as xr
goes to inﬁnity. The ﬂuorescence signal is then determined by
convolving this concentration distribution with a Gaussian beam
proﬁle. xr was determined from the lateral Gaussian proﬁle of the
point spread function (PSF) of our system, measured with 100-nm
ﬂuorescent microspheres (Molecular Probes) in water and injected
into a cerebellar slice. Mean ± SD xr in water was
0.57 ± 0.05 lm and that in the tissue was 0.53 ± 0.01 lm
(n ¼ 10). The percentage of total immobilized PV* (immobile
fraction, IF) is 100 · Fi/bleach depth. The bleach depth is the
amplitude – measured from F0 – of the signal immediately after
the bleach pulse and related but not identical to b (Brown et al.
1999).
The ﬁrst second of the somatic and nuclear recovery were
described with the 3D diffusion equation given in Brown et al.
(1999), with an added offset to explore possible binding of PV*
in these compartments:
F ðtÞ¼FiþF1
X1
n¼0
m3=2ðbÞn
n!ðmþbnþðbnmt=sDÞÞ
1
mþbnþðbnmt=RsDÞð Þ1=2
½2
with the characteristic radial diffusion time sD ¼ x2r /8D, and the
ratio of the beam dimensions R ¼ x2z /x2r , where xz is the axial e)2
radius of the two-photon excitation volume (mean ± SD xz was
1.8 ± 0.1 lm in water and 1.95 ± 0.12 lm in slices). The para-
meters m and b represent the number of photons absorbed per
molecule in a ﬂuorescence and bleaching event respectively.
Ignoring possible higher-order processes, we used m ¼ b ¼ 2, i.e.
two-photon events. During ﬁtting, the series were truncated after the
sixth partial sum. The reliability of all ﬁts was judged by inspection
of the residuals (i.e. data – ﬁt).
Results
FRAP principles and axonal mobility of PV*
We used two-photon FRAP to analyse the mobility of Alexa-
488-labelled parvalbumin (PV*) in PNs and to search for
indications of PV binding partners. PNs were loaded with
PV* via a somatic whole-cell patch pipette for at least
30 min before making FRAP recordings. The pipette
contained 100 lM PV*, a concentration similar to or smaller
than the assumed somatic or axonal concentration of native
PV respectively (Kosaka et al. 1993). After the 30-min
equilibration time, the morphology of the cells (spines,
dendrites, soma, nucleus, axon) could be clearly resolved
under two-photon excitation, indicating that PV* had free
access to all cellular compartments. For FRAP experiments
the laser beam was directed to a single point of interest and a
brief high-intensity laser pulse was applied to irreversibly
bleach the ﬂuorophores within the focal volume (FV).
Subsequently, the recovery of the ﬂuorescence, which
reﬂects diffusion of unbleached PV* molecules from neigh-
bouring regions into the FV, was monitored at low laser
intensity (Fig. 1).
The size of the FV was determined from the PSF of the
microscope, measured with ﬂuorescent microspheres with
diameters (100 nm) well below the optical resolution. From
the Gaussian proﬁles of the microsphere signal the radial (xr)
and axial (xz) radii of the two-photon spot at the e
)2
ﬂuorescence intensity were determined to be 0.53 and
1.95 lm respectively. Thus, the axonal radius ( 0.5 lm;
Fig. 1) is smaller than xz and xr, and FRAP in the axon can
be regarded as 1D diffusion in a pipe. In analogy to the 3D
diffusion equation in Brown et al. (1999), we derived a 1D
diffusion equation for the axon (equation 1 in Experimental
Procedures) that quantiﬁes diffusional mobility in terms of
the apparent diffusion coefﬁcient (D). This equation well
described individual as well as averaged recordings (Figs 1b
and c respectively).
In FRAP experiments, binding of PV* to a large or
immobile target would result in a steady-state offset from
the prebleach level (Luby-Phelps et al. 1995; Star et al.
2002; Schmidt et al. 2005; for a detailed discussion of
FRAP time courses see Reits and Neefjes 2001; Sprague
et al. 2004). In order to reveal such targets, our diffusion
equation included an offset as an additional variable.
Normalizing this offset to the maximum decrease in the
ﬂuorescence induced during bleaching (bleach depth)
quantiﬁes the immobile fraction (IF) of PV* (Luby-Phelps
et al. 1995; Schmidt et al. 2003a, 2005). In the example
illustrated in Fig. 1(b), the ﬂuorescence fully returned to the
prebleaching level (deviation < 1%), indicating that no IF of
PV* was present in the axon. Averaging FRAP recordings
obtained at different axonal sites signiﬁcantly increased the
signal-to-noise ratio (Fig. 1c) but yielded indistinguishable
offsets. On average (54 FRAP recordings, ﬁve cells, three
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mice), the mean ± SEM IF was 1.7 ± 1.2%. This value was
not signiﬁcantly different from zero (t-test against a
hypothetical distribution around zero that had a width and
sample size identical to the distribution of the measured
IFs). Thus, no signiﬁcant binding of PV* to a large or
immobile partner occurred in the axon.
The presence of small or rapid-kinetic binding partners
would be characterized by a reduced diffusional mobility
with a smaller D value but a full recovery of the ﬂuorescence
after bleaching (‘retarded’ or ‘effective diffusion’; Crank
1995; Sprague et al. 2004). Such interactions are not readily
identiﬁed in FRAP recordings but require measurements in
different cellular compartments as well as with substances
that certainly lack cellular binding partners. Thus, we
quantiﬁed D in the individual axonal recordings and
derived a median value of 12 (IQR 6–20) lm2/s. By
averaging recordings from the same axon, performed with
identical protocols and showing similar bleach depths
(Fig. 1c), we could narrow the error range to a mean ±
SEM of 12 ± 2 lm2/s.
In spiny dendrites of PNs, the D of PV* has been reported
to be 43 lm2/s (Schmidt et al. 2003a), i.e. a value three to
four times larger than the axonal D found here. In view of
this discrepancy, we controlled the purity and quality of PV*
by sodium dodecyl sulphate (SDS)–polyacrylamide gel
electrophoresis (Fig. 2a). A single protein band with an
apparent molecular weight (Mr) slightly less than 15 kDa
(expected Mr  12 kDa) was seen in samples with the
unlabelled PV and with PV*. As expected the band in the
PV* sample migrated slightly more slowly than PV, in line
with the small increase in Mr due to the Alexa label. Thus,
the reduced axonal mobility of PV does not result from an
improper protein.
10 ms
1.0
0.6
-0.1
0.1
40k FD in water
PV PV*
D ~ 47 μm2/s
F/
F 0
(b)
(a)
Fig. 2 Quality of PV* and FRAP accuracy. (a) Coomassie Blue-
stained SDS–polyacrylamide gel (15%) of 250 lg recombinant PV and
PV* (middle and right lanes respectively). The left lane shows
molecular weight markers (from bottom to top): 10, 15, 20, 25, 37, 50,
75, 100, 150, and 250 kDa. (b) Average of 50 cuvette FRAP curves of
500 lM 40-kDa (40k) FD in water (lower panel). The grey line repre-
sents a ﬁt with a 3D diffusion equation (equation 2 in Experimental
Procedures), and the upper panel the residuals.
500 ms
50 ms
F/
F 0
F/
F 0
50 ms
0.4
- 0.4
1.0
0.5
0
max
1.5
D ~ 10 μm2/s
2 μmPV*
1.0
0.5
In
t.
(a)
(b)
(c)
Fig. 1 PV* is freely mobile in axons of PNs. (a) Two-photon image of
an axonal segment of a PN ﬁlled with 100 lM PV* via a somatic patch
pipette (not shown). Part of the soma is visible to the left. The cross-
hair marks the point of interest from which the FRAP recording illus-
trated in (b) was taken. (b) Normalized axonal FRAP time course (F/
F0, middle) ﬁtted to a 1D diffusion equation (equation 1 in Experimental
Procedures; grey line, D  12 lm2/s). The trace above the recovery
curve shows the residuals and the top panel depicts a scheme of the
laser intensity protocol (Int.). The lower panel shows the initial 200 ms
of the ﬂuorescence recovery on an expanded time scale. Note the
rapid and complete baseline return of the ﬂuorescence after the bleach
pulse, which indicates the absence of a large or immobile binding
partner of PV*. (c) Average of 10 FRAP recordings obtained from the
axon in (a) ﬁtted with the 1D diffusion equation (grey line).
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We further tested whether our experimental approach and
the original 3D equation (Brown et al. 1999; equation 2 in
Experimental Procedures), from which our 1D equation was
derived, yields results consistent with published D values. To
this end, FRAP measurements were performed in an aqueous
solution of 40-kDa FD (Fig. 2b). Four independent samples
of 50 averaged recordings each were ﬁtted to equation 2,
yielding a mean ± SEM D of 43 ± 5 lm2/s at 22C. This
estimate is almost identical to the value of 44 ± 5 lm2/s
reported by Arrio-Dupont et al. (1996).
Taken together, no technical aspects appeared to account
for the observed difference between the axonal and
dendritic PV* mobility. Thus, the discrepancy could be
indicative of retarded diffusion owing to binding of PV*
to a mobile axonal target. On the other hand, differences
in cytoplasmic properties (i.e. viscosity and tortuosity) of
dendrites and axons could also account for the discrepancy
(Crank 1995; Sprague et al. 2004). In order to distinguish
between these two possibilities we performed axonal
FRAP experiments with 10-kDa and 40-kDa FD, for
which no cellular interaction partner would be expected.
As for PV*, individual and averaged recovery curves were
well described by our 1D diffusion equation for both
dextrans (Fig. 3). For 10-kDa FD, ﬂuorescence recovery
occurred with a median D of 10 (IQR 6–15) lm2/s (n ¼
20, four cells, three mice), a value not statistically different
from DPV*. The 40-kDa FD, however, recovered signiﬁ-
cantly more slowly from bleaching than PV* (p < 0.001;
Mann–Whitney rank sum test). The median D was 5.5
(IQR 3–10) lm2/s (n ¼ 17, four cells, three mice). In
spiny dendrites D values of 32 and 20 lm2/s have been
reported for 10-kDa and 40-kDa FD respectively (Schmidt
et al. 2003a). These values are again three- to four-fold
larger than the present axonal values. This indicates that
the reduced axonal mobility of PV* was not due to a
speciﬁc PV interaction, but instead more likely the result
of differences in the cytoplasmic properties of dendrites
and axons.
During the experiments, we distinguished between the
axon initial segment ( 20 lm from the soma; Clark et al.
2005) and the remainder of the axon. However, no differ-
ences were observed in D and IF values between these two
axonal segments. Consequently, the data were pooled to
represent the axonal mobility. Taken together, the data
presented show that no large or immobile PV* binding
ligand is present in the axon of PNs and further argue against
any speciﬁc axonal PV* interactions with small and/or rapid-
kinetic partners.
Somatic and nuclear mobility of PV*
We observed that PV* not only labelled the somata of PNs
but also reached the nuclei, indicating that PV can readily
pass the pores of the nuclear envelope. Because this property
is a prerequisite for a transcription factor, such as the recently
identiﬁed EF-hand CaBP downstream regulatory element
antagonist modulator (DREAM) (Carrion et al. 1999), in the
next set of experiments we analysed FRAP of PV* in the
soma and nucleus (Fig. 4). FRAP in these two compartments
is governed by 3D diffusion into the FV. Consequently, we
used the previously published 3D diffusion equation (Brown
et al. 1999) to quantify the somatic and nuclear PV*
mobility.
We started by exploring possible immobilization of PV*
in the soma or nucleus in terms of the IF that was
introduced into the ﬁtting function (see equation 2). The
mean ± SEM IF in the soma was found to be )1 ± 1%
and that in the nucleus was )1.1 ± 3% (Fig. 5a). Thus,
within the scatter range, the ﬂuorescence completely
recovered to the prebleaching level in both compartments,
indicating that there was no signiﬁcant interaction of PV
with a large or immobile partner in either the soma or
nucleus.
As in the axon, we next quantiﬁed the somatic and nuclear
mobility of PV* in terms of the median D. In both
compartments, it was found to be 11 lm2/s [somatic IQR
7–16 lm2/s (n ¼ 28); nuclear IQR 4–16 lm2/s (n ¼ 33);
ﬁve cells each] (Fig. 5b). This value is similar to D in the
axon but smaller than that in spiny dendrites (Schmidt et al.
2003a). Therefore, we again explored the possibility of
retarded diffusion (see above) by performing FRAP experi-
ments with 10- and 40-kDa FD in the soma and the nucleus.
Fitting these data with the 3D diffusion equation yielded
median D values of 9 (IQR 8–12) and 8 (IQR 7–10) lm2/s
(n ¼ 10, three cells) for somatic and nuclear diffusion of 10-
kDa FD respectively (Fig. 5b). For 40-kDa FD, a signiﬁ-
500 ms 500 ms
(a) (c)
(b) (d)
F/
F 0
F/
F 0
50 ms 50 ms
50 ms 50 ms
1.0
0.4
1.4
10k FD
D ~ 10 μm2/s D ~ 6 μm2/s
F/
F 0
F/
F 0
1.0
0.4
1.4
40k FD
1.0
0.4
1.0
0.5
Fig. 3 Axonal diffusion of FDs. (a) Axonal FRAP measured with a
10-kDa (10k) FD and the corresponding ﬁt of the 1D diffusion equation
(grey line; D  8 lm2/s). The lower panel shows the ﬁrst 200 ms of the
recovery expanded in time. (b) Fit of the 1D diffusion equation to an
average of six recovery curves obtained with 10-kDa FD on the same
cell as in (a). (c and d) Same as in (a) and (b) respectively, but with 40-
kDa (40k) FD; D  4 lm2/s in (c).
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cantly smaller median D of 6 lm2/s was found in both
compartments [somatic IQR 5–8 lm2/s (n ¼ 17); nuclear
IQR 4–8 lm2/s (n ¼ 15); three cells each; p £ 0.001, Mann–
Whitney rank sum test). Thus diffusion was three- to four-
fold slower than that in dendrites (see above), providing
evidence against speciﬁc PV* interactions in the soma and
nucleus of PNs.
Relationship between diffusional mobility and molecular
weight
The Stokes–Einstein relationship predicts that in aqueous
environments the D value of molecules much larger than
water molecules is proportional to their hydrodynamic
radius. Thus, for relatively large molecules, such as dextrans,
D should be approximately proportional to the inverse cubic
root of the Mr (Pusch and Neher 1988; Koch 1999). We
previously found that this relationship holds for dextrans in
dendrites, but is much steeper for CaBPs (Schmidt et al.
2003a, 2005).
We tested for the Stokes–Einstein relationship in axons,
somata and nuclei by plotting the logarithms of the obtained
Fig. 5 Summary of FRAP data. (a) The mean + SEM fraction of PV*
that remained immobilized on the time scale of the FRAP experiments
in axons, somata and nuclei. For comparison, dye-labelled calbindin
(CB*) data for spines, dendrites and axons are reproduced from
Schmidt et al. (2005). (b) Median ± IQR diffusion coefﬁcients (D) of
PV*, 10-kDa (10k) FD and 40-kDa (40k) FD in axons, somata and
nuclei. The asterisks indicate signiﬁcant differences between the
40-kDa FD data and the PV*/10-kDa FD data (ANOVA, p 6 0,001). (c)
Logarithms of the median D values of 10-kDa FD, 40-kDa FD and PV*
plotted against the logarithms of their Mr values. The line represents a
ﬁt to the FD data with the slope set to ) 1/3.
4 μm
20 ms
20 ms
(a)
(c)
(b)
-0.2
0.2
-0.2
0.2
F/
F 0
Nucleus
Soma
1.2
1.0
0.6
0.8
F/
F 0
1.2
1.0
0.6
0.8
D ~ 10 μm2/s
D ~ 11 μm2/s
PV*
Fig. 4 PV* freely diffuses in somata and nuclei of PNs. (a) PV*
labelled the soma and the nucleus. The dashed white lines indicate the
position of the patch pipette (not in focus). The cross-hairs mark the
points for FRAP recordings shown in (b) and (c). (b) Lower panel:
normalized somatic ﬂuorescence recovery and a corresponding 3D
diffusion ﬁt (grey line). The upper panel shows the residuals. (c) Same
as in (b) but for the nuclear FRAP experiment.
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D values of FDs and PV* against the logarithms of the
corresponding Mr values (Fig. 5c). For this analysis, the data
of the three compartments were pooled. We found a good
overlap for the dextran values, with a regression line with the
slope set to ) 1/3. Similar to the situation in dendrites, a clear
(but here non-signiﬁcant) deviation of PV* from this line
was observed. Thus, as in dendrites, the Stokes–Einstein
relationships appear to hold approximately when comparing
FDs of different Mr in axons, somata and nuclei but
presumably not in comparing FDs and proteins. This
discrepancy is most likely explained by the tertiary structure
of FDs and proteins (Kretsinger and Nockolds 1973; Arrio-
Dupont et al. 1996).
Given that the Stokes–Einstein relationship holds for FDs
and an even steeper dependency might be expected for
CaBPs (Schmidt et al. 2005), we tried to estimate the
smallest size of a PV binding ligand that would be revealed
in our FRAP experiments with statistical conﬁdence. To this
end, we systematically varied the D values obtained for 10-
kDa FD until we derived a D that was signiﬁcantly smaller
than DPV*. This ‘statistically distinct D’ takes into account
the scatter of the data and the sample size. Based on the
Stokes–Einstein relationship it was converted to a ‘statisti-
cally distinct Mr’ for a PV binding partner. This conversion
yielded an upper limit for an undetected ligand of 9 kDa.
Discussion
Using two-photon FRAP experiments, we quantiﬁed diffu-
sion of the endogenous CaBP PV in the axon, soma and
nucleus of cerebellar PNs and found no indications for a PV
binding ligand in these compartments. Because there was
also no evidence in spiny dendrites for binding of PV to
intracellular targets (Schmidt et al. 2003a) our data substan-
tiate the notion that, at least in PNs, PV functions as a Ca2+
buffer and lacks a Ca2+ sensor function.
Diffusional exchange between neuronal dendrites and
spines is often quantiﬁed by exponential ﬁtting of FRAP time
courses (Svoboda et al. 1996; Majewska et al. 2000; Star
et al. 2002; Schmidt et al. 2003a, 2005). In order to provide
comparability between different cellular compartments, this
approach requires conversion of the time constants (s) into D
values. Because s is related to D by the morphology of the
structure under investigation, this presupposes a detailed
anatomical knowledge. For example, the spino-dendritic s
reﬂects diffusion through a pipe (the spine neck), whereas the
axonal s results from diffusion within a pipe. Obviously, s
values cannot be compared directly. Our equation for 1D
diffusion offers the advantage that a detailed knowledge of
the morphology under investigation is not required, as long
as the diameter of the cellular structure is well below the
axial and radial extension of the FV. Thus, the present
approach can be applied to thin cylindrical structures such as
axons and distal dendrites.
The possibility of PV binding to target molecules was
explored in two ways: in terms of the IF, which is revealed
by an incomplete recovery of ﬂuorescence after bleaching,
and by comparing the diffusional mobility of PV* with
that of 10- and 40-kDa FD. It has been shown previously
that the IF is a convenient measure to identify intracellular
targets of dye-labelled proteins if the following criteria are
met. First, the target molecule has to be immobile or at least
of considerable size and, second, the off rate of the interac-
tion has to be small compared with the diffusional mobility
(Luby-Phelps et al. 1995; Reits and Neefjes 2001; Star et al.
2002; Sprague et al. 2004; Schmidt et al. 2005). Thus, the
observed absence of an IF in all three compartments argues
against the presence of a large or immobile PV ligand.
In the axon, the absence of an IF came to some extent as a
surprise. Based on quantitative immunogold staining, the PV
concentration in axons of rat PNs has been estimated to be
 1 mM and  100 lM in somata and dendrites (Kosaka
et al. 1993), suggesting partial immobilization of PV in the
axon as a possible adsorption mechanism. How can we
reconcile this discrepancy with our FRAP data? First, it
could be that PV is incorporated into a stable protein
complex, such that our dye-labelled PV could not replace the
native PV. However, given that our experiments were
performed between 30 and 120 min in the whole-cell
conﬁguration, this would require complex stabilities of
several hours, which we consider unlikely. Second, in
several cases it was observed that CaBP antibody recognition
depends on the Ca2+-binding status of the protein (Winsky
and Kuznicki 1996; Zimmermann and Schwaller 2002; B.
Schwaller and P. Racay, unpublished data). Thus, differences
in the metal-binding status of PV in different compartments
might yield ‘apparent’ concentration differences. Finally, the
previously reported densities of immunogold particles in
axons and somata or dendrites varied by a factor of only 2.5
(Kosaka et al. 1993). The subsequent concentration estimate
was based on an in vitro standard curve that showed a strong
non-linearity above PV concentrations of  100 lM, render-
ing the concentration estimates between 100 lM and 2 mM
rather error prone. Taken together, there is no obvious cause
for the discrepancy between the immunohistochemical data
and our FRAP data. This topic requires further investigation.
FRAP in the presence of small or rapid-kinetic binding
partners is characterized by retarded diffusion with a smaller
D value but a full ﬂuorescence recovery after bleaching
(‘effective diffusion’; Crank 1995; Sprague et al. 2004). We
found that DPV* values in axons, somata and nuclei were
three times smaller than those in spiny dendrites of rodent
PNs (Schmidt et al. 2003a) and in frog myoplasm (Maughan
and Godt 1999). This raised the possibility of ‘retarded
diffusion’ of PV* owing to the existence of a small, non-
dendritic binding partner. Based on experiments performed
with FDs, however, we exclude the existence of PV*
interaction sites with Mr ‡ 9 kDa. Thus, the reduced mobility
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may be explained either by systematic errors in our
experimental approach or by differences in cytoplasmic
properties between dendrites and axons; it is unlikely to
reﬂect speciﬁc interactions.
The experimental and theoretical approach taken here
has previously been shown to yield D values for green
ﬂuorescent protein diffusion consistent with the literature
(Swaminathan et al. 1997; Brown et al. 1999). Furthermore,
in the present study we demonstrated that the aqueous
mobility of 40-kDa FD is also consistent with published
values (Arrio-Dupont et al. 1996), making it unlikely that
our experimental design or mathematical formulae led to
systematically reduced D values. Thus, we consider differ-
ences in the cytoplasmic properties as a more likely cause.
These may include the viscosity, tortuosity, and the density of
ﬁbres or organelles in the respective cytosolic compartments.
For example, microtubules in axons are usually more closely
spaced than those in dendrites. Furthermore, although
characteristic somatic organelles such as the Golgi apparatus
or rough endoplasmic reticulum extend into proximal
dendritic structures, they diminish at more distal sites (Fiala
and Harris 2005). In the nucleus a high concentration of
chromatin (Lafarga et al. 1991) could contribute to the
reduced mobility of PV*.
To conclude, we have presented evidence that PV lacks
speciﬁc intracellular targets in cerebellar PNs and so
probably functions as a pure Ca2+ buffer in these cells. The
obtained D values provide a foundation for realistic simu-
lations of neuronal Ca2+ signalling in the presence of PV.
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